Clinical Trials Directory

Trials / Completed

CompletedNCT03782714

Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies

Clinical and Radiographic Evaluation of Low-level Laser Therapy in Human Primary Molar Pulpotomies: A Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
King Abdulaziz University · Academic / Other
Sex
All
Age
5 Years – 8 Years
Healthy volunteers
Accepted

Summary

This study aimed to assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth. One hundred and six primary molars from 36 children aging five to eight years were included and randomly assigned into two equal groups; LLLT group and FC group. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

Detailed description

Background: Various agents are available to dress the remaining pulp tissue after pulpotomy procedure with the formocresol (FC) being the gold standard for the last 60 years. Nowadays, low-level laser therapy (LLLT) becomes a technique of interest, due to its many characteristics. However, the literature available on its success in pulpotomy is limited and reported conflicting results. Aim of the study: To assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth. Materials and methods: Utilizing split-mouth technique, the sample consisted of 106 primary molars from 36 children aging five to eight years. The teeth were selected based on specific clinical and radiographic inclusion criteria and randomly assigned into two equal groups; LLLT group and FC group. All the 106 primary molars were indicated for pulpotomy, where 53 teeth were treated using FC and 53 teeth were treated with LLLT. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

Conditions

Interventions

TypeNameDescription
DEVICELow-level laser therapyIt is a diode laser device that has laser set at low level, used for pain relief and inflammation reduction to induce healing

Timeline

Start date
2017-02-01
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2018-12-20
Last updated
2018-12-20

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT03782714. Inclusion in this directory is not an endorsement.